The Geboes Score is a six-grade system that pathologists use to measure the severity of microscopic inflammation in tissue samples from people with ulcerative colitis (UC). Developed in 2000 as a way to standardize what had been highly subjective assessments of colon biopsies, it grades inflammation from 0 (structural changes only, no active disease) through 5 (erosions or ulcers).1Gut. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis The score has become one of the most widely used histological indices in UC research and clinical trials, though the way doctors apply it in everyday practice and the questions it raises about “deep healing” are more interesting than the grading system itself.
What the Score Actually Measures
When a gastroenterologist performs a colonoscopy and takes small tissue samples from the colon lining, those biopsies go to a pathologist who examines them under a microscope. The Geboes Score gives that pathologist a structured way to describe what they see, moving through progressively more severe types of inflammation. The six main grades are:
- Grade 0: Structural changes only, such as altered crypt architecture, without active inflammation.
- Grade 1: Chronic inflammatory cells present in the deeper tissue layer (lamina propria), but no neutrophils, which are the white blood cells that signal active flare-ups.
- Grade 2: Neutrophils have appeared in the lamina propria, split into 2A (in the connective tissue) and 2B (adjacent to the gland-like crypts in the colon wall).
- Grade 3: Neutrophils have invaded the crypt lining itself, a feature called cryptitis.
- Grade 4: Crypt destruction, where the glands that line the colon are being damaged or destroyed.
- Grade 5: Erosions or ulcers visible under the microscope.
Each of these main grades is further divided into subcategories that capture severity within the grade. Most grades have four subcategories (like 0.0, 0.1, 0.2, 0.3), while Grade 5 has five (5.0 through 5.4).2PubMed Central. A Comparative Evaluation of the Measurement Properties of Three Histological Indices of Mucosal Healing in Ulcerative Colitis – Section: 2.2.1. Geboes Score This fine-tuning within each grade was part of the original design and gives researchers and clinicians more precision than a simple six-point scale would allow.
Why Grade 3 Gets Special Attention
Of all six grades, Grade 3 (neutrophils in the crypt epithelium) has emerged as a particularly important threshold. A Geboes score of 3.1 or higher is widely used as the cutoff for “histologically active” disease, meaning the tissue shows signs of ongoing active inflammation even if the patient feels well or the colon looks normal during a colonoscopy. The subcategories within Grade 3 are assigned based on what percentage of crypts are affected: Grade 3.1 means fewer than 5% of crypts show neutrophil infiltration, Grade 3.2 means fewer than 50%, and Grade 3.3 means more than half.3PubMed Central. Geboes Histopathology Score Grade 3 Subclassification Predicts Treatment Response in Active Ulcerative Colitis
This matters clinically because a patient who is in remission by every visible measure can still have active histological inflammation. Research has found that active inflammation at or above Geboes 3.1 appeared in 6% of tissue samples from colons that looked completely normal under the endoscope, and in a striking 66% of samples showing only mild endoscopic disease.4PubMed Central. Correlation between Histological Activity and Endoscopic, Clinical, and Serologic Activities in Patients with Ulcerative Colitis In other words, the microscope often tells a different story than the camera, and that hidden inflammation has consequences.
Predicting Relapse and Flare-Ups
The Geboes Score’s most valuable clinical role is helping predict which patients in apparent remission are likely to flare again. Several studies have demonstrated that patients who achieve not just endoscopic healing (a colon that looks normal on camera) but also histological healing (a Geboes score showing no active inflammation) have meaningfully lower relapse rates.
In a study of 270 patients who had achieved endoscopic healing, about 55% also had histological remission at the same time. Over roughly two and a half years, those with histological remission had a substantially lower risk of clinical relapse and hospitalization. The one-year relapse risk was about 19% for patients with histological remission compared to nearly 30% for those without it.5PubMed Central. Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing A separate study found that complete histological healing on the Geboes Score was associated with reduced rates of clinical relapse even among patients already in full endoscopic remission.6PubMed Central. Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission
When researchers combined the Geboes Score with endoscopic assessment, the predictive power got even sharper. Patients with both a low endoscopic score and a Geboes score at or below 3.0 had a one-year relapse avoidance that was 92% sensitive and 97% specific, and active histological inflammation (Geboes above 3.0) was an independent risk factor for relapse with a hazard ratio of about 3.5.7PubMed. Pancolonic endoscopic and histologic evaluation for relapse prediction in patients with ulcerative colitis in clinical remission Those numbers are strong enough that many specialists now view histological assessment as a genuine upgrade over endoscopy alone for long-term disease monitoring.
Beyond Relapse: Predicting Colectomy
Relapse is one concern, but the more serious question for many UC patients is whether they might eventually need surgery to remove part or all of their colon. Research has shown that the Geboes Score carries predictive weight here as well. Patients starting biologic therapy with a baseline Geboes Grade of 4 (crypt destruction) had a higher risk of needing colectomy during treatment compared to those with lower grades. Patients with a Geboes Grade above 5.0 had a significantly higher risk of colectomy over longer follow-up, and this held up even after accounting for what the colon looked like endoscopically.8Inflammatory Bowel Diseases. Histological, But Neither Clinical Nor Endoscopic Activity Predicts the Risk of Colectomy in Patients With Ulcerative Colitis Treated With Biologics
This finding is particularly striking because it suggests that histological activity captures prognostic information that neither clinical symptoms nor the endoscopic appearance of the colon can provide. For patients with severe microscopic disease that is not adequately reflected on colonoscopy, a high Geboes Score could be an early warning signal that more aggressive treatment is warranted.
How Deep Is Deep Remission?
The Geboes Score has helped refine the concept of “deep remission” in UC, which loosely means the disease is quiet at every level: the patient feels fine, the colon looks healthy on camera, and the microscopic picture is clean. But how clean is clean enough? Even within the lowest Geboes grades, gradations matter. Patients who achieved a Simplified Geboes Score of 0 (complete mucosal normalization) had a one-year cumulative relapse risk of about 2%, compared to roughly 14% for those with scores of 0.1 to 0.2, representing very mild residual abnormalities. Median time to relapse was 39 months for the completely normalized group versus about 27 months for the near-normal group.9PubMed Central. Predictors and Etiologies of Clinical Relapse Among Patients with Ulcerative Colitis in Deep Remission
That gap suggests the scoring system can distinguish between patients who are truly healed and those who retain subclinical inflammation likely to cause problems later. For patients and their doctors, this raises a practical question: should treatment aim for a Geboes Score of zero rather than simply “low”? The evidence increasingly leans toward yes, though in practice this can mean more treatment, more biopsies, and higher costs.
The Simplified Version
One persistent criticism of the original Geboes Score is that it is complicated to use in daily clinical practice. With six main grades, subcategories within each grade, and the need to evaluate multiple tissue features, the scoring process can be time-consuming and demands considerable pathology expertise. This led to the development of a Simplified Geboes Score (SGS), which condenses the system while retaining its core structure and clinical relevance.10PubMed. A Simplified Geboes Score for Ulcerative Colitis
The simplified version has gained traction in both research and routine care. As noted above, the SGS was used to identify relapse risk even within the deep remission group, demonstrating that the slimmed-down system still captures clinically meaningful differences. Several recent clinical trials now report outcomes using the Simplified Geboes Score alongside or instead of the original.
How It Compares to Other Histological Scores
The Geboes Score is not the only game in town. The Robarts Histopathology Index (RHI) and the Nancy Index are two other validated scoring systems that pathologists use to grade UC inflammation. An international consensus effort found that all three were considered appropriate for assessing histological activity in clinical trials.11PubMed Central. An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials
In head-to-head comparisons, the Geboes Score and the RHI track closely. A study comparing the two found a correlation coefficient of 0.806, and they agreed on whether a patient had achieved histological response in 88 to 95% of cases.12Journal of Crohn’s and Colitis. Comparing the Continuous Geboes Score With the Robarts Histopathology Index The Nancy Index is generally considered simpler, with fewer categories, while the RHI produces a continuous numerical score that can be useful for measuring incremental change in trials. The Geboes Score’s advantage is its long track record and wide adoption: it has been used in more published studies than either competitor, which means more data on its prognostic value and more consensus around what its cutoffs mean in practice.
That said, the measurement properties of these three indices have also been formally compared, and no single index decisively outperforms the others across all scenarios.13PubMed Central. A Comparative Evaluation of the Measurement Properties of Three Histological Indices of Mucosal Healing in Ulcerative Colitis The choice often comes down to what a particular trial or clinic has traditionally used, and whether the pathologists involved are more comfortable with a categorical system (Geboes, Nancy) or a continuous one (RHI).
The Reproducibility Challenge
A scoring system is only useful if different pathologists looking at the same biopsy arrive at the same grade. Here, the Geboes Score’s track record is mixed. Agreement between pathologists tends to be good for detecting the presence of histological activity (the 3.1 threshold), and for several individual grades like Grades 1, 2B, and 3. But it is only moderate for Grades 0 and 2A, and poor for Grade 4 (crypt destruction).14Journal of Medical Sciences and Health. Evaluation of Simplified Geboes Score in Ulcerative Colitis A study in pediatric UC found moderate interobserver agreement for the Geboes Score overall, with a kappa of 0.46, which was lower than the agreement seen for the Nancy and Robarts indices in the same patients.
This variability is not unique to the Geboes Score. Histological scoring in UC is inherently subjective, and even the best-designed systems leave room for disagreement at the borders between grades. The practical consequence is that a single biopsy read by a single pathologist should be interpreted cautiously. Many experts recommend that in trial settings, a central pathologist or panel review biopsies rather than relying on local reads alone.
How Many Biopsies Are Enough?
Even a perfectly reproducible scoring system can give misleading results if the tissue sample is not representative. Inflammation in UC, despite being considered “continuous,” is actually distributed unevenly at the microscopic level. Features like cryptitis and erosions that contribute directly to the Geboes grade may be present in one spot and absent a few millimeters away. Research on biopsy sampling density has shown that the accuracy of histological assessment improves substantially when at least two or three biopsies are taken from each site, with diminishing returns from additional samples beyond that.15Inflammatory Bowel Diseases. Density of Biopsy Sampling Required to Ensure Accurate Histological Assessment of Inflammation in Active Ulcerative Colitis
This has real implications for clinical trials, where a Geboes Score endpoint applied to an insufficient number of biopsies could produce noisy or unreliable data. It also matters in routine care: if your doctor takes only a single biopsy from a segment of your colon, the resulting Geboes Score may not capture the full picture of what is going on in that area.
Artificial Intelligence and the Future of Scoring
Given the challenges of interobserver variability and the time-consuming nature of manual scoring, several research groups have turned to artificial intelligence to automate Geboes Score assessment. Deep learning models trained on thousands of biopsy images from clinical trials have shown moderate to substantial agreement with expert human pathologists at distinguishing between Geboes grades.16Journal of Crohn’s and Colitis. Deep Learning Models Capture Histological Disease Activity in Crohn’s Disease and Ulcerative Colitis with High Fidelity
A more recent effort involving a consortium of researchers developed an AI-based tool trained on over 10,000 UC biopsies that could predict individual Geboes subgrades and derive the overall score, as well as the RHI and Nancy Index, from the same images. The tool was found to be at least as good as qualified pathologists for all Geboes subgrades and was actually superior for several of them. Perhaps most strikingly, the AI tool was more than 99% repeatable: it gave the same answer on the same biopsy every time, something no human reader can claim.17PubMed Central. Standardized, repeatable ulcerative colitis histology scoring and endpoint assessment using an automated, foundation model-based tool If validated further, tools like this could address the reproducibility problem at scale and make histological endpoints in clinical trials far more consistent.
Where the Geboes Score Sits in the Treatment Conversation
For patients with UC, the practical relevance of the Geboes Score comes down to a shift in how treatment goals are defined. A decade ago, getting a patient to feel better and have a normal-looking colonoscopy was considered a success. Now, the evidence increasingly suggests that aiming for histological healing on top of endoscopic healing provides a meaningfully better long-term outlook: fewer relapses, fewer hospitalizations, and potentially less risk of surgery.
Not every gastroenterologist routinely orders biopsy-based histological scoring for patients in clinical remission, and guidelines vary on whether histological endpoints should be treatment targets or merely useful information. But the trend is clear, and the Geboes Score sits at the center of it. If your doctor mentions that they want to check biopsies even though your colonoscopy looked good, this is the kind of scoring framework driving that decision. The microscope sees what the camera misses, and how much inflammation it finds can change what happens next.